Pineal parenchymal tumors (PPTs) are rare neoplasms which occupy less than 1% of primary central nervous system tumors. Because of their rare incidence, the previous reports on PPTs are limited in number and the useful molecular markers for deciding the histological grading and even selecting chemotherapy are undetermined. In this study, 
Introduction
Pineal parenchymal tumors (PPTs) are rare neoplasms arising from the pineal gland, and account for less than 1% of primary central nervous system (CNS) tumors are limited because of the rare incidence of PPT. Moreover, the therapeutic modality to high grade PPTs have yet to be standardized; these range from localized radiotherapy to cranio-spinal radiotherapy, radical resection and multidrug chemotherapy 4 .
Temozolomide (TMZ) is an oral alkylating agent which is widely used in the treatment of glioblastoma. Recently, TMZ has been applied to other neuro-oncological tumors including pituitary tumor, melanomas, neuroendocrine tumors and metastatic tumors [5] [6] [7] [8] [9] [10] . O 6 -methylguanine DNA methyltransferase (MGMT) is a DNA repair protein that reverses alkylation at the O 6 position of guanine and counteracts the anti-neoplastic effect of TMZ. As previous studies showed an inverse correlation between MGMT expression and responsiveness to TMZ 11-13 , the examination of MGMT expression is important to predict the response to TMZ therapy. PPTs could be one of the potential therapeutic targets for TMZ; however, no data is available about MGMT expression in PPTs so far.
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In this study, we evaluated the expression of MGMT in 12 cases of PPT to assess whether TMZ could be one of the possible therapeutic agents for PPTs. In addition, to clarify the state of differentiation or biological characteristics of each grades of PPTs, we also evaluated the immunohistochemical molecular expression of PPTs including MIB-1 labeling index as a proliferation marker, and the major prognostic markers of PPTs reported in previously 14, 15 such as Neurofilament (NF); the most famous tumor suppressor, p53; and NeuN, the neuronal marker.
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Materials and Methods
Between 1992 and 2011, 12 patients were diagnosed as PPT in our faculty. The microscopic slides, paraffin-embedded tissue and clinical information of these patients were collected retrospectively. For histological examinations, formalin-fixed, paraffin-embedded tissue was sectioned to 3 m, and stained using hematoxylin and eosin (H&E) . We reassessed the histological diagnoses according to the latest WHO classification. The differentiation between PPTID Grade II and PPTID Grade III was defined according to morphologic and immunohistochemical features described in the previous report [Jouvet, 2000 #18] . Mitoses were counted in 10 randomly selected high power fields (HPFs, x400) and expressed as the number of mitoses per 10 HPFs as previously described [Jouvet, 2000 #18] .
Immunohistochemistry was performed according to standard procedures. Briefly, tissue sections of 5 m were deparaffinized. Antigen retrieval was carried out using pressure cooking (in citrate buffer for 3 min). Endogenous peroxidase activity was blocked by incubating sections in 3% hydrogen peroxide for 5 min. After blocking, tissue sections were incubated with the primary antibodies listed in Table 1 
Results
Histological examination
Characteristics of the patients and immunohistochemical results are summarized in Table 2 . The patients consisted of 3 males and 9 females with a median age of 53.5 years (range, 24-71). Three cases were classified as pineocytoma (Cases 1-3), six as PPTID (Cases 4-9), and three as pineoblastoma (Cases 10-12).
Pineocytomas demonstrated low to moderate cellularity and large pineocytomatous rosettes with abundant cell processes. The cells were uniform and had round-to-oval nuclei (Fig. 1a) . PPTIDs showed moderate to high cellularity and rosette-like formation but lacked conspicuous pineocytomatous rosettes. The nuclear atypia was mild to moderate ( Fig. 2a ). There were no mitotic figures or necroses in pineocytomas and PPTIDs. Pineoblastomas were composed of highly cellular, patternless sheets of small undifferentiated cells. The cells showed high nuclear cytoplasmic ratio and hyperchromatic nuclei (Fig. 3a ). Mitoses were seen in 2 pineoblastoma cases, which corresponded to 3 and 1 /10 HPFs, respectively, and one case demonstrated necrosis.
The histological appearances of the other 9 cases are indicated in the Supplementary figure.
Immunohistochemistry
MGMT expression was detected in almost all cases except 1 pineocytoma (Fig. 1b, 2b, 3b and Supplementary figures 2c, 2f, 2i, 2l, 2o, 2r, 2u, 2x, 2A); in particular, all
PPTIDs and pineoblastomas showed maximum staining intensity. The mean MIB-1 (Fig. 1e, Supplementary figures 1c, 1e) , and NF staining was present in almost all cases except the 1 PPTID case (Figs. 1c, 2c, 3c ). There was no difference in NF-positivity between pineocytomas and the other types of PPTs. ; however, an evident standardized therapeutic protocol for PPTIDs and pineoblastoma has not been established. Table 3 .
Our result of the mean MIB-1 labeling index was consistent with the previous studies which reported the mean MIB-1 labeling indices as 0.27 -3.9 % in pineocytoma, 2.7 -10.1 % in PPTID, and 6.49 -36.4 % in pineoblastoma 14, 15, 26 . We failed to obtain the positive staining of p53 in immunohistochemistry as shown in previous report 27 .
Meanwhile, our staining result of NF was not relevant to previous reports. Jouvet et al reported that PPTIDs and pineoblastomas were less positive for NF, and positive immunostaining for NF was associated with a better survival 1 . In this study, immunoreactivity of NF was observed in all types of PPTs not associated with the histological grade, although we have to consider the limited number of the cases in our 11 study.
We also analyzed the expression of NeuN, which is a neuron-specific nuclear protein widely used in neurodevelopmental research and histopathologic diagnosis 28, 29 .
Immunohitochemically, NeuN was not detected in the nucleus of any PPTs, while some PPTIDs and pineoblastomas demonstrated cytoplasmic staining of NeuN in a dot-like manner (Fig. 2d) . Although some previous reports suggest the cytoplasmic expression of NeuN, the functional significance has not been determined 30 .
In conclusion, our immunohistochemical result of MGMT expression in the majority of PPTs let us endeavor to find the effective chemotherapeutic agents for high grade PPTs other than TMZ. In addition, the MIB-1 labeling index will help to reach to proper WHO grade of PPTs. MIB-1 labeling index is 12.7 %. a-e: x400 
Figure Legends
